Overview

TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery

Status:
Completed
Trial end date:
2019-05-29
Target enrollment:
0
Participant gender:
All
Summary
This is a prospective randomized study designed to compare the pain control from a single shot of liposomal bupivacaine (Exparel) against transversus abominus plane (TAP) catheters with ropivicaine bolus in patients undergoing elective colorectal surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of California, Davis
Treatments:
Bupivacaine
Ropivacaine
Criteria
Inclusion Criteria:

- Patients scheduled for elective colorectal surgery with Dr. Linda Farkas

Exclusion Criteria:

- Patients under 18 years of age

- Patient over 90 years of age

- Pregnancy

- Prisoners

- Patients unable to provide consent

- Patients on systemic anticoagulation therapy

- Patients with an allergy to local anesthetics